ELS-tíðindi - janúar 2002 - Einkaleyfastofan
ELS-tíðindi - janúar 2002 - Einkaleyfastofan
ELS-tíðindi - janúar 2002 - Einkaleyfastofan
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
68 <strong>ELS</strong> <strong>tíðindi</strong> 1/02<br />
(21) 6158<br />
(22) 13.11.2001<br />
(41) 13.11.2001<br />
(51) C07D 401/12; C07D 401/14; A61K<br />
31/495<br />
(54) Pýrazínón þrombín latar.<br />
(71) Merck & Co., Inc., 126 East Lincoln<br />
Avenue, Rahway, New Jersey<br />
07065-0907, Bandaríkjunum.<br />
(72) Christopher S. Burgey; Kyle A.<br />
Robinson; Peter D. Williams; Craig<br />
A. Coburn; Terry A. Lyle; Philip E.<br />
Sanderson; Rahway, New Jersey,<br />
Bandaríkjunum.<br />
(74) Faktor einkaleyfaskrifstofa, ehf.,<br />
Pósthólf 678, 121 Reykjavík.<br />
(30) 4.6.99, US, 60/137,538<br />
16.7.99, US, 60/144,291<br />
(85) 13.11.2001<br />
(86) 1.6.2000, PCT/US00/15140<br />
(21) 6159<br />
(22) 13.11.2001<br />
(41) 13.11.2001<br />
(51) C07D 453/02; A61K 31/439; A61P<br />
1/08<br />
(54) Fjölgervingar af kristölluðu<br />
asabísýkló (2,2,2) oktan-3-amín<br />
sítrati og lyfjasamsetningar.<br />
(71) Pfizer Product Inc., Eastern Point<br />
Road, Groton, Connecticut 06340,<br />
Bandaríkjunum.<br />
(72) Michael James Castaldi; George<br />
Joseph Quallich; Lewin Theophilus<br />
Wint; Groton, Connecticut,<br />
Bandaríkjunum.<br />
(74) Faktor einkaleyfaskrifstofa, ehf.,<br />
Pósthólf 678, 121 Reykjavík.<br />
(30) 1.6.99, US, 60/136,992<br />
(85) 13.11.2001<br />
(86) 18.5.2000, PCT/IB00/00665<br />
(21) 6160<br />
(22) 13.11.2001<br />
(41) 13.11.2001<br />
(51) C07H 17/08; A61K 31/70; A61P 31/04<br />
(54) Dífosfat salt af 4"-setinni-9-deoxó-<br />
9A-asa-9A-hómóerýtrómysín afleiðu<br />
og lyfjasamsetning þar af.<br />
(71) Pfizer Product Inc., Eastern Point<br />
Road, Groton, Connecticut 06340,<br />
Bandaríkjunum.<br />
(72) Robert John Rafka; Colman Brendan<br />
Ragan; Douglas John Meldrum<br />
Allen; Groton, Connecticut,<br />
Bandaríkjunum.<br />
(74) Faktor einkaleyfaskrifstofa, ehf.,<br />
Pósthólf 678, 121 Reykjavík.<br />
(30) 30.6.99, US, 60/141,681<br />
(85) 13.11.2001<br />
(86) 13.6.2000, PCT/IB00/00785<br />
(21) 6161<br />
(22) 13.11.2001<br />
(41) 13.11.2001<br />
(51) C07D 453/02; A61K 31/435; A61P<br />
25/28<br />
(54) Fjölgervingar af kristölluðu (2benshýdrýl-1-azabísýkló<br />
[2,2,2]okt-<br />
3-ýl)-(5-ísóprópýl-2-metoxýbensýl)ammóníumklóríði<br />
sem NK-1 viðtaka<br />
mótlyf.<br />
(71) Pfizer Product Inc., Eastern Point<br />
Road, Groton, Connecticut 06340,<br />
Bandaríkjunum.<br />
(72) Douglas John Meldrum Allen; Troy<br />
Anthony Appleton; Michael Jon<br />
Gumkowski; David Joseph<br />
Muehlbauer; Timothy Norris; Groton,<br />
Connecticut, Bandaríkjunum.<br />
(74) Faktor einkaleyfaskrifstofa, ehf.,<br />
Pósthólf 678, 121 Reykjavík.<br />
(30) 22.6.99, US, 60/140,233<br />
(85) 13.11.2001<br />
(86) 6.6.2000, PCT/IB00/00756<br />
(21) 6163<br />
(22) 16.11.2001<br />
(41) 16.11.2001<br />
(51) A61K 47/48<br />
(54) Lyfjakomplex.<br />
(71) Pfizer Inc., 235 East 42nd Street,<br />
New York, New York 10017,<br />
Bandaríkjunum.<br />
(72) Anne Billotte, Sandwich, Kent,<br />
Bretlandi.<br />
(74) Faktor einkaleyfaskrifstofa, ehf.,<br />
Pósthólf 678, 121 Reykjavík.<br />
(30) 29.6.99, GB, 9915231.6<br />
(85) 16.11.2001<br />
(86) 2.6.2000, PCT/IB00/00746<br />
(21) 6164<br />
(22) 16.11.2001<br />
(41) 16.11.2001<br />
(51) A61K 31/451; A61K 31/4523; C07D<br />
401/10; A61K 31/453; C07D 405/14;<br />
C07D 401/14; C07D 211/22; C07D<br />
405/12; C07D 211/26; C07D 417/10;<br />
A61P 9/00<br />
(54) Málmpróteasa latar.<br />
(71) Pfizer Inc., 235 East 42nd Street,<br />
New York, New York 10017,<br />
Bandaríkjunum.<br />
(72) Kevin Neil Dack; Michael Jonathan<br />
Fray; Gavin Alistair Whitlock; Mark<br />
Llewellyn Lewis; Nicholas Murray<br />
Thomson; Sandwich, Kent,<br />
Bretlandi.<br />
(74) Faktor einkaleyfaskrifstofa, ehf.,<br />
Pósthólf 678, 121 Reykjavík.<br />
(30) 3.6.99, GB, 9912961.1<br />
(85) 16.11.2001<br />
(86) 18.5.2000, PCT/IB00/00667<br />
(21) 6165<br />
(22) 16.11.2001<br />
(41) 16.11.2001<br />
(51) C07H 19/167; A61K 31/70; A61P 11/00;<br />
A61P 9/00<br />
(54) Púrín afleiður.<br />
(71) Pfizer Inc., 235 East 42nd Street,<br />
New York, New York 10017,<br />
Bandaríkjunum.<br />
(72) Sandra Marina Monaghan,<br />
Sandwich, Kent, Bretlandi.<br />
(74) Faktor einkaleyfaskrifstofa, ehf.,<br />
Pósthólf 678, 121 Reykjavík.<br />
(30) 14.10.99, GB, 9924363.6<br />
(85) 16.11.2001<br />
(86) 6.10.2000, PCT/IB00/01444<br />
(21) 6166<br />
(22) 19.11.2001<br />
(41) 19.11.2001<br />
(51) C07D 239/42; C07D 409/04; C07D<br />
401/04; C07D 403/12; A61K 31/505;<br />
A61K 31/506; A61P 9/14<br />
(54) 5-sýanó-2-amínópýrimidín afleiður.<br />
(71) Celltech R&D Limited, 208 Bath<br />
Road, Slough, Berkshire SL1 3WE,<br />
Bretlandi.<br />
(72) Mark James Batchelor, Watlington,<br />
Oxfordshire; David Festus Charles<br />
Moffat, Maidenhead, Berkshire;<br />
Jeremy Martin Davis, Wokingham,<br />
Berkshire; Martin Clive Hutchings,<br />
Wokingham, Berkshire; Bretlandi.<br />
(74) Sigurjónsson & Thor, ehf.,<br />
Skólavörðustíg 16, 101 Reykjavík.<br />
(30) 18.6.99, GB, 9914258.0<br />
(85) 19.11.2001<br />
(86) 19.6.2000, PCT/GB00/02382<br />
(21) 6168<br />
(22) 20.11.2001<br />
(41) 20.11.2001<br />
(51) F16K 31/12<br />
(54) Vökvaflæði- og þrýstistýrikerfi og<br />
aðferð.<br />
(71) M-I L.L.C., P.O. Box 42842, Houston,<br />
Texas 77242-2842, Bandaríkjunum.<br />
(72) Roger Suter, Edmond, Oklahoma;<br />
Lester L. Cain; Bandaríkjunum.<br />
(74) A&P Árnason ehf., Efstaleiti 5, 103<br />
Reykjavík.<br />
(30) 21.5.99, US, 09/316,579<br />
(85) 20.11.2001<br />
(86) 28.4.2000, PCT/US00/11404<br />
(21) 6169<br />
(22) 21.11.2001<br />
(41) 21.11.2001<br />
(51) E04C 2/34<br />
(54) Léttur byggingarþáttur á formi hols<br />
meginhluta með uppbyggingu<br />
sexhyrnds yfirborðs.<br />
(71) Peter Küppers, Kaiserstiege 143,<br />
D-48599 Gronau, Þýskalandi.<br />
(72) Peter Küppers, Gronau, Þýskalandi.<br />
(74) Faktor einkaleyfaskrifstofa, ehf.,<br />
Pósthólf 678, 121 Reykjavík.<br />
(30) 27.5.99, DE, 199 24 332.8<br />
10.5.2000, DE, 100 22 742.2<br />
(85) 21.11.2001<br />
(86) 25.5.2000, PCT/DE00/01683